vs

Side-by-side financial comparison of MYRIAD GENETICS INC (MYGN) and ORMAT TECHNOLOGIES, INC. (ORA). Click either name above to swap in a different company.

ORMAT TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($276.0M vs $209.8M, roughly 1.3× MYRIAD GENETICS INC). On growth, ORMAT TECHNOLOGIES, INC. posted the faster year-over-year revenue change (19.6% vs -0.4%). Over the past eight quarters, ORMAT TECHNOLOGIES, INC.'s revenue compounded faster (11.0% CAGR vs 1.9%).

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

Ormat Technologies, Inc. is an international company based in Reno, Nevada, United States. Ormat supplies alternative and renewable geothermal energy technology. The company has built over 190 power plants and installed over 3,200 MW of output. As of January 2021 it owns and operates 933 MW of geothermal and recovered energy based power plants. Ormat has supplied over 1000 turbochargers worldwide, in North America, South America, Europe, Australia, and Asia. The company's products also includ...

MYGN vs ORA — Head-to-Head

Bigger by revenue
ORA
ORA
1.3× larger
ORA
$276.0M
$209.8M
MYGN
Growing faster (revenue YoY)
ORA
ORA
+20.0% gap
ORA
19.6%
-0.4%
MYGN
Faster 2-yr revenue CAGR
ORA
ORA
Annualised
ORA
11.0%
1.9%
MYGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MYGN
MYGN
ORA
ORA
Revenue
$209.8M
$276.0M
Net Profit
$31.4M
Gross Margin
70.0%
28.6%
Operating Margin
-2.7%
15.4%
Net Margin
11.4%
Revenue YoY
-0.4%
19.6%
Net Profit YoY
-23.2%
EPS (diluted)
$-0.09
$0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYGN
MYGN
ORA
ORA
Q4 25
$209.8M
$276.0M
Q3 25
$205.7M
$249.7M
Q2 25
$213.1M
$234.0M
Q1 25
$195.9M
$229.8M
Q4 24
$210.6M
$230.7M
Q3 24
$213.3M
$211.8M
Q2 24
$211.5M
$213.0M
Q1 24
$202.2M
$224.2M
Net Profit
MYGN
MYGN
ORA
ORA
Q4 25
$31.4M
Q3 25
$-27.4M
$24.1M
Q2 25
$-330.5M
$28.0M
Q1 25
$-100.0K
$40.4M
Q4 24
$40.8M
Q3 24
$-22.1M
$22.1M
Q2 24
$-36.7M
$22.2M
Q1 24
$-26.0M
$38.6M
Gross Margin
MYGN
MYGN
ORA
ORA
Q4 25
70.0%
28.6%
Q3 25
69.9%
25.6%
Q2 25
71.2%
24.3%
Q1 25
68.5%
31.7%
Q4 24
71.7%
31.9%
Q3 24
70.2%
27.8%
Q2 24
69.6%
28.8%
Q1 24
68.1%
35.2%
Operating Margin
MYGN
MYGN
ORA
ORA
Q4 25
-2.7%
15.4%
Q3 25
-11.3%
16.2%
Q2 25
-154.5%
15.1%
Q1 25
-14.8%
22.2%
Q4 24
-18.6%
21.3%
Q3 24
-9.4%
16.8%
Q2 24
-17.3%
16.5%
Q1 24
-13.8%
23.5%
Net Margin
MYGN
MYGN
ORA
ORA
Q4 25
11.4%
Q3 25
-13.3%
9.7%
Q2 25
-155.1%
12.0%
Q1 25
-0.1%
17.6%
Q4 24
17.7%
Q3 24
-10.4%
10.4%
Q2 24
-17.4%
10.4%
Q1 24
-12.9%
17.2%
EPS (diluted)
MYGN
MYGN
ORA
ORA
Q4 25
$-0.09
$0.51
Q3 25
$-0.29
$0.39
Q2 25
$-3.57
$0.46
Q1 25
$0.00
$0.66
Q4 24
$-0.47
$0.67
Q3 24
$-0.24
$0.36
Q2 24
$-0.41
$0.37
Q1 24
$-0.29
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYGN
MYGN
ORA
ORA
Cash + ST InvestmentsLiquidity on hand
$149.6M
$147.4M
Total DebtLower is stronger
$119.9M
$2.7B
Stockholders' EquityBook value
$368.0M
$2.5B
Total Assets
$706.6M
$6.2B
Debt / EquityLower = less leverage
0.33×
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYGN
MYGN
ORA
ORA
Q4 25
$149.6M
$147.4M
Q3 25
$145.4M
$79.6M
Q2 25
$74.4M
$88.5M
Q1 25
$91.8M
$112.7M
Q4 24
$102.4M
$94.4M
Q3 24
$99.9M
$88.1M
Q2 24
$97.3M
$66.3M
Q1 24
$104.3M
$201.5M
Total Debt
MYGN
MYGN
ORA
ORA
Q4 25
$119.9M
$2.7B
Q3 25
$119.5M
Q2 25
Q1 25
Q4 24
$2.3B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MYGN
MYGN
ORA
ORA
Q4 25
$368.0M
$2.5B
Q3 25
$372.8M
$2.5B
Q2 25
$388.1M
$2.5B
Q1 25
$704.9M
$2.5B
Q4 24
$701.1M
$2.4B
Q3 24
$731.7M
$2.4B
Q2 24
$740.5M
$2.4B
Q1 24
$760.0M
$2.4B
Total Assets
MYGN
MYGN
ORA
ORA
Q4 25
$706.6M
$6.2B
Q3 25
$728.1M
$6.1B
Q2 25
$677.3M
$6.0B
Q1 25
$1.0B
$5.8B
Q4 24
$1.0B
$5.7B
Q3 24
$1.1B
$5.6B
Q2 24
$1.1B
$5.5B
Q1 24
$1.1B
$5.5B
Debt / Equity
MYGN
MYGN
ORA
ORA
Q4 25
0.33×
1.05×
Q3 25
0.32×
Q2 25
Q1 25
Q4 24
0.97×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYGN
MYGN
ORA
ORA
Operating Cash FlowLast quarter
$10.6M
$105.0M
Free Cash FlowOCF − Capex
$-40.0M
FCF MarginFCF / Revenue
-14.5%
Capex IntensityCapex / Revenue
52.6%
Cash ConversionOCF / Net Profit
3.35×
TTM Free Cash FlowTrailing 4 quarters
$-284.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYGN
MYGN
ORA
ORA
Q4 25
$10.6M
$105.0M
Q3 25
$21.1M
$45.2M
Q2 25
$-13.6M
$96.9M
Q1 25
$-16.3M
$88.0M
Q4 24
$6.6M
$158.6M
Q3 24
$700.0K
$106.4M
Q2 24
$2.6M
$30.7M
Q1 24
$-18.6M
$115.2M
Free Cash Flow
MYGN
MYGN
ORA
ORA
Q4 25
$-40.0M
Q3 25
$-102.1M
Q2 25
$-37.9M
Q1 25
$-104.6M
Q4 24
$30.9M
Q3 24
$-3.3M
Q2 24
$-116.1M
Q1 24
$11.8M
FCF Margin
MYGN
MYGN
ORA
ORA
Q4 25
-14.5%
Q3 25
-40.9%
Q2 25
-16.2%
Q1 25
-45.5%
Q4 24
13.4%
Q3 24
-1.6%
Q2 24
-54.5%
Q1 24
5.3%
Capex Intensity
MYGN
MYGN
ORA
ORA
Q4 25
52.6%
Q3 25
59.0%
Q2 25
57.6%
Q1 25
83.8%
Q4 24
55.4%
Q3 24
51.8%
Q2 24
69.0%
Q1 24
46.1%
Cash Conversion
MYGN
MYGN
ORA
ORA
Q4 25
3.35×
Q3 25
1.87×
Q2 25
3.45×
Q1 25
2.18×
Q4 24
3.89×
Q3 24
4.82×
Q2 24
1.38×
Q1 24
2.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MYGN
MYGN

Segment breakdown not available.

ORA
ORA

Electricity$186.6M68%
Products$63.1M23%
Energy Storage Segment$26.3M10%
Product Segment$1.2M0%

Related Comparisons